Health Care/Hospital

Nippon Express Italia Acquires GDP Certification for Company-owned Warehouse near Milan Malpensa Airport

TOKYO, July 14, 2021 /PRNewswire/ -- Nippon Express Italia S.P.A. (hereinafter " NE Italy"), a local subsidiary of Nippon Express Co., Ltd., obtained Good Distribution Practice (GDP) certification from the certification body CERTIQUALITY S.r.l., effectiveMay 25, for its company-owned warehouse nea...

2021-07-14 15:00 1112

A Drop for Clear Vision: Japan Has Surpassed Itself Again with the Development of Ultra-High-Concentration Lutein

TAIPEI, July 14, 2021 /PRNewswire/ -- According to the World Report on Vision published in 2020 by World Health Organization (WHO), the incidence of most eye diseases and visual impairments varies by age, area of residence, and income level. As people age, the risk of developing cataracts, presby...

2021-07-14 11:32 1255

Kintor Pharmaceutical Receives IND Clearance by the U.S. FDA for GT20029 to Treat Androgenetic Alopecia and Acne

SUZHOU, China, July 13, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX:9939), a clinical-stage biotechnology company developing innovative small-molecule and biological therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared an Investigational New Drug...

2021-07-14 07:05 17140

Listen to Your Body with the Newly-launched Amazfit PowerBuds Pro; TWS Earbuds with Advanced Health Monitoring Features

CUPERTINO, Calif., July 13, 2021 /PRNewswire/ -- Today, Amazfit , a brand of Zepp Health (NYSE: ZEPP), launched the Amazfit PowerBuds Pro - their new true wireless stereo (TWS) earbuds with advanced health monitoring features and powerful multi-scenario active noise ...

2021-07-13 21:00 17855

Zepp Health Introduces Next Gen Smart Wearable Chip, Smartwatch OS and Blood Pressure Measurement at Annual Developers Conference

HEFEI, China, July 13, 2021 /PRNewswire/ -- Zepp Health Corp. (NYSE: ZEPP) today  hostedNext Beat 2021 – The Future of Heath, the company's annual developers conference, which included the announcement of several key company developments. Huangsha...

2021-07-13 19:41 16792

GenScript to Host Gene & Cell Engineering Virtual Summit

PISCATAWAY, N.J. , July 13, 2021 /PRNewswire/ -- GenScript® , the world's leading life science service provider, announced today the firstGenScript Gene & Cell Engineering Virtual Summit,

2021-07-13 19:30 48008

Nuctech™ Kylin Care Wins the German Red Dot Award, the "Oscar of the Design World"

BEIJING, July 12, 2021 /PRNewswire/ -- Recently, the German Red Dot Design Award, also known as the "Oscar of the design world", has been officially announced, and Nuctech has won the Red Dot: Best of the Best award, the top prize of Red Dot Award: Design Concept.

2021-07-13 11:30 1283

CD47 Monoclonal Antibody (AK117) Completed Phase I Dose Escalation Trial and Obtained Approval to Initiate Clinical Trial in Combination with Azacitidine for Treatment of Acute Myeloid Leukemia

HONG KONG, July 12, 2021 /PRNewswire/ -- Akeso, Inc. is pleased to announce that, CD47 monoclonal antibody (AK117), a second-generation novel drug for immuno-oncology therapy independently developed by the Company, has completed phase I dose escalation trial inAustralia. AK117 resulted in no dose...

2021-07-13 09:06 1837

Hochuen Medical Raises Tens of Millions RMB in Series A Financing

SHENZHEN, July 12, 2021 /PRNewswire/ -- Hochuen Medical Technology Co., Ltd. (hereinafter referred to as "Hochuen Medical") has raised a40 million Yuan (RMB) Series A round of financing led by Qiming Venture Partners as the sole investor. The new proceeds will be used to (1) accelerate the com...

2021-07-13 01:05 1653

Nippon Express France Acquires GDP Certification for Company-owned Warehouse near Paris Charles de Gaulle Airport

TOKYO, July 12, 2021 /PRNewswire/ -- Nippon Express France, S.A.S. (hereinafter "NE France"), a local subsidiary of Nippon Express Co., Ltd., obtained Good Distribution Practice (GDP) certification from the certification body Bureau Veritas Certification France, effectiveMay 19, for air and truck...

2021-07-12 14:00 2768

Kintor Pharmaceutical Announced FDA Has Greenlighted Pyrilutamide's Phase II Clinical Trial for Androgenetic Alopecia in the US

SUZHOU, China, July 11, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX:9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has greenlighted pyrilutamide's phase...

2021-07-11 21:03 19083

HICOOL 2021 Global Entrepreneurship Competition (Preliminary Round) is Launched in Full Swing on July 10th

BEIJING, July 11, 2021 /PRNewswire/ -- On July 10th, HICOOL 2021 Global Entrepreneurship Competition (Qualifying Round) is launched in full swing. A total of 1,237 startups shortlisted for the preliminary round compete off-line inBeijing and online in a global context in six major industries: New...

2021-07-11 21:00 1619

BGI Statement in Response to Reuters Report

SHENZHEN, China, July 9, 2021 /PRNewswire/ -- BGI is aware of reports in Reuters regarding the company's non-invasive prenatal test (NIPT test) - NIFTY (Non-Invasive Fetal TrisomY). BGI's NIPT tests have been used around the world to identify genetic conditions in pregnancy. These tests provide ...

2021-07-09 21:50 30852

ABL Bio Announces Publication of Preclinical Data Demonstrating Safety and Efficacy of ABL503/TJ-L14B, a Novel Anti-PD-L1 X 4-1BB Bispecific Antibody

* ABL503/TJ-L14B demonstrates stronger anti-tumor efficacy than anti-PD-L1 or anti-4-1BB monotherapy as well as a good safety profile * ABL503 currently in Phase 1 trial to evaluate the safety, tolerability, MTD PK and PD in patients with advanced or metastatic solid tumors SEONGNAM, South Ko...

2021-07-09 21:00 2679

I-Mab Expands Emerging Portfolio of Next Generation Novel Oncology Therapeutics Through Cutting-Edge mRNA and AI Technology Platforms

SHANGHAI and GAITHERSBURG, Md., July 9, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced the signing of two new collaborations with emerging biote...

2021-07-09 20:00 29862

Hanjiao Group Launches its Home Care Service Cloud Platform

BEIJING, July 9, 2021 /PRNewswire/ -- Hanjiao Group, Inc. ("Hanjiao" or the "Company")  (OTC Pink: HJGP), aNevada corporation engaged in the distribution of healthcare and other related products to the middle-aged and elderly market segments in the PRC through its online e-Commerce platform and o...

2021-07-09 19:30 31548

Sequanta and Mission Bio announce strategic partnership

SHANGHAI, July 8, 2021 /PRNewswire/ -- Sequanta Technologies Co., Ltd. ("Sequanta") and Mission Bio. ("Mission Bio") are pleased to announce that they have entered into a strategic partnership, providing high-quality single-cell sequence services using Mission Bio's products to customers in mainl...

2021-07-09 15:44 1577

Nippon Express (India) Newly Acquires GDP Certification at Three Locations

TOKYO, July 8, 2021 /PRNewswire/ -- Nippon Express (India) Private Limited (hereinafter "NE India"), a local subsidiary of Nippon Express Co., Ltd., obtained Good Distribution Practice (GDP) certification in April for its temperature-controlled hubs inDelhi, Mumbai and Ahmedabad, evidencing the ...

2021-07-08 15:00 922

BioShin Expands Senior Leadership Team: Sarah Lu Joins BioShin as Chief Medical Officer, Mary Ma Joins BioShin as Chief Commercial Officer

SHANGHAI, July 8, 2021 /PRNewswire/ -- BioShin Limited today announced the appointment of Dr.Zhihong (Sarah) Lu as Chief Medical Officer and Dr. Ma (Mary) Li as Chief Commercial Officer. Sarah will play a critical role in BioShin's clinical development of pipeline products inAsia-Pacific markets,...

2021-07-08 12:01 2007

Harbour BioMed Reports Positive Topline Results from Phase 2 Trial of Batoclimab (HBM9161) in Generalized Myasthenia Gravis

* Both batoclimab 340 mg and 680 mg treatment groups demonstrated rapid, substantial and persistent clinical improvement over placebo * Favorable safety and tolerability profile with no serious adverse events (SAEs) and no adverse events (AEs) leading to discontinuation * Strong IgG reductio...

2021-07-06 21:06 17790
1 ... 170171172173174175176 ... 255